# EDGAR Filing Document

**Accession Number:** 0000074046
**File Stem:** 0000074046-23-000010
**Filing Date:** 2023-3
**Character Count:** 139954
**Document Hash:** 62211421cedc4ebae9b29bcf47e72408
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000074046-23-000010.hdr.sgml**: 20230309

**ACCESSION NUMBER**: 0000074046-23-000010

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 71

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230309

**DATE AS OF CHANGE**: 20230309

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oil-Dri Corp of America
- **CENTRAL INDEX KEY:** 0000074046
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
- **IRS NUMBER:** 362048898
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12622
- **FILM NUMBER:** 23719981

**BUSINESS ADDRESS:**
- **STREET 1:** 410 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 400
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** 3123211515

**MAIL ADDRESS:**
- **STREET 1:** 410 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 400
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OIL-DRI Corp OF AMERICA
- **DATE OF NAME CHANGE:** 20170417

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OIL DRI CORP OF AMERICA
- **DATE OF NAME CHANGE:** 20170307

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OIL-DRI CORP OF AMERICA
- **DATE OF NAME CHANGE:** 20170306

?xml version="1.0" ? odc-20230131

    

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

(Mark One)

☒&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended January 31, 2023

or

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934For the transition period from _____________ to ______________

Commission File Number 001-12622

<u>OIL-DRI CORPORATION OF AMERICA</u> 

(Exact name of the registrant as specified in its charter)

<u>Delaware</u> <u>36-2048898</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;410 North Michigan Avenue, Suite 400 <u>60611-4213</u> 

<u>Chicago, Illinois</u> (Zip Code)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices)

The registrant's telephone number, including area code: (312) 321-1515

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for at least the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer □ Accelerated Filer ⌧ Non-accelerated Filer □ Smaller Reporting Company ⌧ Emerging Growth Company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.10 per share | ODC | New York Stock Exchange |

---

Indicate the number of shares outstanding of each of the issuer's classes of common stock as of January 31, 2023.

Common Stock – 5,119,546 Shares and Class B Stock – 2,045,415 Shares

------

**CONTENTS**

---

| | | |
|:---|:---|:---|
| | **PART I – FINANCIAL INFORMATION** | |
| | | **<u>Page</u>** |
| **Item 1:** | [Financial Statements](#i6c26fc8b3d4d4f4897cd39a680ba69ac_13) | <u>[3](#i6c26fc8b3d4d4f4897cd39a680ba69ac_13)</u> |
| **Item 2:** | [Management's Discussion and Analysis of Financial Condition and Results Of Operations](#i6c26fc8b3d4d4f4897cd39a680ba69ac_88) | <u>[23](#i6c26fc8b3d4d4f4897cd39a680ba69ac_88)</u> |
| **Item 4:** | [Controls and Procedures](#i6c26fc8b3d4d4f4897cd39a680ba69ac_118) | <u>[31](#i6c26fc8b3d4d4f4897cd39a680ba69ac_118)</u> |
|  | **PART II – OTHER INFORMATION** |  |
| **Item 1A:** | Risk Factors | <u>[31](#i6c26fc8b3d4d4f4897cd39a680ba69ac_124)</u> |
| **Item 2:** | [Unregistered Sales of Equity Securities and Use of Proceeds](#i6c26fc8b3d4d4f4897cd39a680ba69ac_127)  | <u>[32](#i6c26fc8b3d4d4f4897cd39a680ba69ac_127)</u> |
| **Item 4:** | [Mine Safety Disclosures](#i6c26fc8b3d4d4f4897cd39a680ba69ac_130)  | <u>[32](#i6c26fc8b3d4d4f4897cd39a680ba69ac_130)</u> |
| **Item 6:** | [Exhibits](#i6c26fc8b3d4d4f4897cd39a680ba69ac_136) | <u>[33](#i6c26fc8b3d4d4f4897cd39a680ba69ac_136)</u> |
|  | [Signatures](#i6c26fc8b3d4d4f4897cd39a680ba69ac_139) | <u>[34](#i6c26fc8b3d4d4f4897cd39a680ba69ac_139)</u> |

---

**FORWARD-LOOKING STATEMENTS**

Certain statements in this report, including, but not limited to, those under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations," and those statements elsewhere in this report and other documents that we file with the Securities and Exchange Commission ("SEC"), contain forward-looking statements that are based on current expectations, estimates, forecasts and projections about our future performance, our business, our beliefs and our management's assumptions. In addition, we, or others on our behalf, may make forward-looking statements in press releases or written statements, or in our communications and discussions with investors and analysts in the normal course of business through meetings, webcasts, phone calls and conference calls. Words such as "expect," "outlook," "forecast," "would," "could," "should," "project," "intend," "plan," "continue," "believe," "seek," "estimate," "anticipate," "may," "assume," "potential," "strive," and variations of such words and similar expressions are intended to identify such forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Such statements are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially, including, but not limited to, those described herein and in Item 1A, "Risk Factors", in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022, and from time to time in our filings with the SEC. Should one or more of these or other risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, intended, expected, believed, estimated, projected or planned. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except to the extent required by law, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this report, whether as a result of new information, future events, changes in assumptions or otherwise.

**TRADEMARK NOTICE**

"Oil-Dri" and "Ultra-Clear" are registered trademarks of Oil-Dri Corporation of America.

------

**PART I - FINANCIAL INFORMATION**

**ITEM 1. Financial Statements**

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Balance Sheet**

**(in thousands, except for share and per share amounts)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | |
| **ASSETS** | **January 31,<br>2023** | **July 31,<br>2022** |
| **<u>Current Assets</u>** | | |
| Cash and cash equivalents | $**13951** | $16298 |
| Accounts receivable, net allowances of<br>&nbsp;&nbsp;&nbsp;&nbsp;$1,037 and $922 at January 31, 2023 and July 31, 2022, respectively | **57179** | 51683 |
| Inventories, net | **37938** | 35562 |
| Prepaid repairs | **8107** | 7474 |
| Prepaid expenses and other assets | **2413** | 3664 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Assets** | **119588** | 114681 |
| **<u>Property, Plant and Equipment</u>** |  |  |
| Cost | **292615** | 283240 |
| Less accumulated depreciation and amortization | **(180936)** | (175374) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Property, Plant and Equipment, Net** | **111679** | 107866 |
| **<u>Other Assets</u>** |  |  |
| Goodwill | **3618** | 3618 |
| Trademarks and patents, net of accumulated amortization<br> of $550 and $524 at January 31, 2023 and July 31, 2022, respectively | **1476** | 1445 |
| Customer list, net of accumulated amortization <br>&nbsp;&nbsp;&nbsp;&nbsp;of $7,685 and $7,608 at January 31, 2023 and July 31, 2022, respectively | **100** | 177 |
| Deferred income taxes | **3511** | 3677 |
| Operating lease right-of-use assets | **9460** | 10601 |
| Other | **6612** | 7546 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other Assets** | **24777** | 27064 |
| **Total Assets** | $**256044** | $249611 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Balance Sheet (continued)**

**(in thousands, except for share and per share amounts)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | |
| **LIABILITIES & STOCKHOLDERS' EQUITY** | **January 31,<br>2023** | **July 31,<br>2022** |
| **<u>Current Liabilities</u>** | | |
| Current maturities of notes payable | $**1000** | $1000 |
| Accounts payable | **11048** | 13401 |
| Dividends payable | **1858** | 1851 |
| Operating lease liabilities | **1850** | 2178 |
| Accrued expenses | **33785** | 30085 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Liabilities** | **49541** | 48515 |
| **<u>Noncurrent Liabilities</u>** |  |  |
| Notes payable, net of unamortized debt issuance costs <br> of $191 and $202 at January 31, 2023 and July 31, 2022, respectively | **31809** | 31798 |
| Deferred compensation | **4441** | 4559 |
| Pension and postretirement benefits | **434** | 798 |
| Long-term operating lease liabilities | **8919** | 9749 |
| Other | **3926** | 3843 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Noncurrent Liabilities** | **49529** | 50747 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Liabilities** | **99070** | 99262 |
| **<u>Stockholders' Equity</u>** |  |  |
| Common Stock, par value $.10 per share, issued 8,744,223 shares at January 31, 2023<br>&nbsp;&nbsp;&nbsp;&nbsp;and 8,686,768 shares at July 31, 2022  | **874** | 868 |
| Class B Stock, par value $.10 per share, issued 2,397,056 shares at January 31, 2023<br>&nbsp;&nbsp;&nbsp;&nbsp;and 2,397,056 shares at July 31, 2022 | **240** | 240 |
| Additional paid-in capital | **54328** | 52467 |
| Retained earnings | **184133** | 178754 |
| Noncontrolling interest | **(390)** | (369) |
| Accumulated Other Comprehensive Loss: |  |  |
| &nbsp;&nbsp;&nbsp;Pension and postretirement benefits | **(2255)** | (2242) |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment | **(70)** | 59 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Accumulated Other Comprehensive Loss | **(2325)** | (2183) |
| &nbsp;&nbsp;Less Treasury Stock, at cost (3,624,677 Common and 351,641 Class B shares at <br>January 31, 2023 and 3,609,938 Common and 351,641 Class B shares at July 31, 2022) | **(79886)** | (79428) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Stockholders' Equity** | **156974** | 150349 |
| **Total Liabilities & Stockholders' Equity** | $**256044** | $249611 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Operations**

**(in thousands, except for per share amounts)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | **(unaudited)** |
| | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **2023** | **2022** |
| **Net Sales** | $**200208** | $169670 |
| **Cost of Sales** | **(154882)** | (140266) |
| **Gross Profit** | **45326** | 29404 |
| **Selling, General and Administrative Expenses** | **(31451)** | (27041) |
| **Income from Operations** | **13875** | 2363 |
| **Other (Expense) Income** |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | **(731)** | (490) |
| &nbsp;&nbsp;&nbsp;Interest income | **115** | 17 |
| &nbsp;&nbsp;&nbsp;Other, net | **(1783)** | 1190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other (Expense) Income, Net** | **(2399)** | 717 |
| **Income Before Income Taxes** | **11476** | 3080 |
| **Income Tax Expense** | **(2400)** | (524) |
| **Net Income** | **9076** | 2556 |
| **Net Loss Attributable to Noncontrolling Interest** | **(21)** | (31) |
| **Net Income Attributable to Oil-Dri** | $**9097** | $2587 |
| **Net Income Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | $**1.37** | $0.38 |
| &nbsp;&nbsp;&nbsp;**Basic Class B Common** | $**1.03** | $0.28 |
| &nbsp;&nbsp;&nbsp;**Diluted Common (1)** | $**1.34** | $0.37 |
| **Diluted Class B Common** | $**1.02** | $0.28 |
| **Average Shares Outstanding** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | **4817** | 5095 |
| &nbsp;&nbsp;&nbsp;**Basic Class B Common** | **1953** | 1930 |
| &nbsp;&nbsp;&nbsp;**Diluted Common (1)** | **4937** | 5211 |
| **Diluted Class B Common** | **1975** | 1966 |
| **Dividends Declared Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | $**0.5600** | $0.5400 |
| &nbsp;&nbsp;&nbsp;**Basic Class B Common** | $**0.4200** | $0.4050 |

---

(1) The effect of Basic Common potential common stock equivalents related to non-vested restricted stock of $7 thousand shares was excluded from the computation of average diluted shares outstanding for the six months ended January 31, 2023, as inclusion would have been anti-dilutive.

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Comprehensive Income**

**(in thousands)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | **(unaudited)** |
| | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **2023** | **2022** |
| **Net Income Attributable to Oil-Dri** | $**9097** | $2587 |
| Other Comprehensive (Loss) Income: |  |  |
| &nbsp;&nbsp;&nbsp;Pension and postretirement benefits (net of tax) | **(13)** | 53 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment | **(129)** | (94) |
| **Other Comprehensive Loss** | **(142)** | (41) |
| **Total Comprehensive Income** | $**8955** | $2546 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Operations**

**(in thousands, except for per share amounts)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | **(unaudited)** |
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** |
| | **2023** | **2022** |
| **Net Sales** | $**101669** | $87210 |
| **Cost of Sales** | **(78653)** | (71624) |
| **Gross Profit** | **23016** | 15586 |
| **Selling, General and Administrative Expenses** | **(15710)** | (13668) |
| **Income from Operations** | **7306** | **1918** |
| **Other (Expense) Income** |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | **(367)** | (313) |
| &nbsp;&nbsp;&nbsp;Interest income | **59** | 8 |
| &nbsp;&nbsp;&nbsp;Other, net | **(1959)** | 757 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other (Expense) Income, Net** | **(2267)** | 452 |
| **Income Before Income Taxes** | **5039** | 2370 |
| **Income Tax Expense** | **(1193)** | (409) |
| **Net Income** | **3846** | 1961 |
| **Net Loss Attributable to Noncontrolling Interest** | **(10)** | (41) |
| **Net Income Attributable to Oil-Dri** | $**3856** | $2002 |
| **Net Income Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | $**0.58** | $0.29 |
| &nbsp;&nbsp;&nbsp;**Basic Class B Common** | $**0.44** | $0.22 |
| &nbsp;&nbsp;&nbsp;**Diluted Common (1)** | $**0.56** | $0.28 |
| **Diluted Class B Common** | $**0.43** | $0.22 |
| **Average Shares Outstanding** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | **4829** | 5077 |
| &nbsp;&nbsp;&nbsp;**Basic Class B Common** | **1964** | 1939 |
| &nbsp;&nbsp;&nbsp;**Diluted Common (1)** | **4965** | 5186 |
| **Diluted Class B Common** | **1985** | 1965 |
| **Dividends Declared Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | $**0.2800** | $0.2700 |
| &nbsp;&nbsp;&nbsp;**Basic Class B Common** | $**0.2100** | $0.2025 |

---

(1) The effect of Basic Common potential common stock equivalents related to non-vested restricted stock of 1 thousand shares was excluded from the computation of average diluted shares outstanding for the three months ended January 31, 2023, as inclusion would have been anti-dilutive.

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Comprehensive (Loss) Income**

**(in thousands of dollars)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | **(unaudited)** |
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** |
| | **2023** | **2022** |
| **Net Income Attributable to Oil-Dri** | $**3856** | $2002 |
| Other Comprehensive Income (Loss): |  |  |
| &nbsp;&nbsp;&nbsp;Pension and postretirement benefits (net of tax) | **(5)** | 26 |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment | **256** | (60) |
| **Other Comprehensive Income (Loss)** | **251** | (34) |
| **Total Comprehensive Income** | $**4107** | $1968 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Consolidated Statements of Stockholders' Equity**

**(in thousands, except share amounts)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** | **For the Three Months Ended January 31** |
| | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** |
| | **Number of Shares** | **Number of Shares** | | | | | | | |
| | **Common<br>& Class B<br>Stock** | **Treasury<br>Stock** | **Common<br>& Class B<br>Stock** | **Additional<br>Paid-In<br>Capital** | **Retained<br>Earnings** | **Treasury<br>Stock** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Non-Controlling Interest** | **Total<br>Stockholders'<br>Equity** |
| **Balance, October 31, 2021** | **11033024** | **(3618510)** | $**1103** | $**49377** | $**179164** | $**(68922)** | $**(4124)** | $**(297)** | $**156301** |
| Net Income (Loss) |  |  |  |  | 2002 |  |  | (41) | 1961 |
| Other Comprehensive Loss |  |  |  |  |  |  | (34) |  | (34) |
| Dividends Declared |  |  |  |  | (1844) |  |  |  | (1844) |
| Purchases of Treasury Stock |  | (113236) |  |  |  | (3910) |  |  | (3910) |
| Net issuance of stock under long-term incentive plans | 32000 | (850) | 4 | 26 |  | (30) |  |  |  |
| Amortization of Restricted Stock |  | **—** |  | 817 |  |  |  |  | 817 |
| **Balance, January 31, 2022** | **11065024** | **(3732596)** | $**1107** | $**50220** | $**179322** | $**(72862)** | $**(4158)** | $**(338)** | $**153291** |
| **Balance, October 31, 2022** | **11122674** | **(3968939)** | $**1112** | $**53385** | $**182135** | $**(79648)** | $**(2576)** | $**(380)** | $**154028** |
| Net Income (Loss) |  |  |  |  | 3856 |  |  | (10) | 3846 |
| Other Comprehensive Income |  |  |  |  |  |  | 251 |  | 251 |
| Dividends Declared |  |  |  |  | (1858) |  |  |  | (1858) |
| Purchases of Treasury Stock |  | (4133) |  |  |  | (133) |  |  | (133) |
| Net issuance of stock under long-term incentive plans | 18605 | (3246) | 2 | 103 |  | (105) |  |  |  |
| Amortization of Restricted Stock |  |  |  | 840 |  |  |  |  | 840 |
| **Balance, January 31, 2023** | **11141279** | **(3976318)** | $**1114** | $**54328** | $**184133** | $**(79886)** | $**(2325)** | $**(390)** | $**156974** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** | **For the Six Months Ended January 31** |
| | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** |
| | Number of Shares | Number of Shares | | | | | | | |
| | Common & Class B Stock | Treasury Stock |<br>Common & Class B Stock |<br>Additional Paid-In Capital |<br>Retained Earnings |<br>Treasury Stock |<br>Accumulated Other Comprehensive Loss |<br>Non-controlling Interest |<br>Total Stockholders' Equity |
| **Balance, July 31, 2021** | **10958367** | **(3539193)** | $**1096** | $**48271** | $**180443** | $**(66154)** | $**(4117)** | $**(307)** | $**159232** |
| Net Income (Loss) |  |  |  |  | 2587 |  |  | (31) | 2556 |
| Other Comprehensive Loss |  |  |  |  |  |  | (41) |  | (41) |
| Dividends Declared |  |  |  |  | (3708) |  |  |  | (3708) |
| Purchases of Treasury Stock |  | (179003) |  |  |  | (6201) |  |  | (6201) |
| Net issuance of stock under long-term incentive plans | 106657 | (14400) | 11 | 496 |  | (507) |  |  |  |
| Amortization of Restricted Stock |  |  |  | 1453 |  |  |  |  | 1453 |
| **Balance, January 31, 2022** | **11065024** | **(3732596)** | $**1107** | $**50220** | $**179322** | $**(72862)** | $**(4158)** | $**(338)** | $**153291** |
| **Balance, July 31, 2022** | **11083824** | **(3961579)** | $**1108** | $**52467** | $**178754** | $**(79428)** | $**(2183)** | $**(369)** | $**150349** |
| Net Income (Loss) |  |  |  |  | 9097 |  |  | (21) | 9076 |
| Other Comprehensive Loss |  |  |  |  |  |  | (142) |  | (142) |
| Dividends Declared |  |  |  |  | (3718) |  |  |  | (3718) |
| Purchases of Treasury Stock |  | (7493) |  |  |  | (225) |  |  | (225) |
| Net issuance of stock under long-term incentive plans | 57455 | (7246) | 6 | 227 |  | (233) |  |  |  |
| Amortization of Restricted Stock |  |  |  | 1634 |  |  |  |  | 1634 |
| **Balance, January 31, 2023** | **11141279** | **(3976318)** | $**1114** | $**54328** | $**184133** | $**(79886)** | $**(2325)** | $**(390)** | $**156974** |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Cash Flows** 

**(in thousands)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | **(unaudited)** |
| | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| **<u>CASH FLOWS FROM OPERATING ACTIVITIES</u>** | **2023** | **2022** |
| **Net Income** | $**9076** | $2556 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **7274** | 6773 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash stock-based compensation | **1634** | 1453 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **166** | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for bad debts and cash discounts | **207** | (59) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on the disposals of property, plant and equipment | **15** | 265 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) Decrease in assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | **(5738)** | (5023) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(2432)** | (6236) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | **(8)** | 846 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | **2030** | 634 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (Decrease) in liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **180** | 1326 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | **3889** | (1595) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred compensation | **(118)** | 690 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement benefits | **(377)** | (616) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | **(900)** | (985) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Adjustments** | **5822** | (2495) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Provided by Operating Activities** | **14898** | 61 |
| **<u>CASH FLOWS FROM INVESTING ACTIVITIES</u>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | **(13285)** | (10574) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant and equipment | **5** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Used in Investing Activities** | **(13280)** | (10574) |
| **<u>CASH FLOWS FROM FINANCING ACTIVITIES</u>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of notes payable | **—** | 25000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of debt issuance costs | **—** | (114) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid | **(3711)** | (3728) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of treasury stock | **(225)** | (6201) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash (Used in) Provided by Financing Activities** | **(3936)** | 14957 |
| Effect of exchange rate changes on Cash and Cash Equivalents | **(29)** | (26) |
| **Net (Decrease) Increase in Cash and Cash Equivalents** | **(2347)** | 4418 |
| **Cash and Cash Equivalents, Beginning of Period** | **16298** | 24591 |
| **Cash and Cash Equivalents, End of Period** | $**13951** | $29009 |

---

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Cash Flows - Continued**

**(in thousands)**

---

| | | |
|:---|:---|:---|
| | **(unaudited)** | **(unaudited)** |
| | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **2023** | **2022** |
| **Supplemental disclosures:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest payments, net of amounts capitalized | $**567** | $178 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax payments | $**1323** | $155 |
| **Non-cash investing and financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures accrued, but not paid | $**1283** | $835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash dividends declared and accrued, but not paid | $**1858** | $1845 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Notes To Condensed Consolidated Financial Statements**

**(Unaudited)**

**1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation**

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements and the related notes are condensed and should be read in conjunction with the Consolidated Financial Statements and related notes for the fiscal year ended July 31, 2022 included in our Annual Report on Form 10-K filed with the SEC.

The unaudited Condensed Consolidated Financial Statements include the accounts of Oil-Dri Corporation of America and its subsidiaries. All significant intercompany transactions are eliminated. Except as otherwise indicated herein or as the context otherwise requires, references to "Oil-Dri," the "Company," "we," "us" or "our" refer to Oil-Dri Corporation of America and its subsidiaries.

The unaudited Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals and reclassifications which are, in the opinion of management, necessary for a fair presentation of the statements contained herein. Operating results for the three and six months ended January 31, 2023 are not necessarily an indication of the results that may be expected for the fiscal year ending July 31, 2023.

**Management Use of Estimates**

The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the reporting period, as well as the related disclosures. Estimates and assumptions about future events cannot be made with certainty. All of our estimates and assumptions are revised periodically. Actual results could differ from these estimates. For more information see "Critical Accounting Policies and Estimates" in Item 2 "Management's Discussion and Analysis of Financial Condition and Results of Operations."

**Summary of Significant Accounting Policies**

Our significant accounting policies, which are summarized in detail in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022, have not materially changed. The following is a description of certain of our significant accounting policies:

**Trade Receivables.** We recognize trade receivables when control of finished products are transferred to our customers. We record an allowance for credit losses based on our expectations and a periodic review of our accounts receivable, including a review of the overall aging of accounts, consideration of customer credit risk and analysis of facts and circumstances about specific accounts. A customer account is determined to be uncollectible when it is probable that a loss will be incurred after we have completed our internal collection procedures, including termination of shipments, direct customer contact and formal demand of payment. We retain outside collection agencies to facilitate our collection efforts. Past due status is determined based on contractual terms and customer payment history.

**Overburden Removal and Mining Costs.** We mine sorbent materials on property that we either own or lease as part of our overall operations. A significant part of our overall mining cost is incurred during the process of removing the overburden (non-usable material) from the mine site, thus exposing the sorbent material used in a majority of our production processes. These stripping costs are treated as a variable inventory production cost and are included in cost of sales in the period they are incurred. We defer and amortize the pre-production overburden removal costs during the development phase associated with opening a new mine.

Additionally, it is our policy to capitalize the purchase cost of land and mineral rights, including associated legal fees, survey fees and real estate fees. The costs of obtaining mineral patents, including legal fees and drilling expenses, are also capitalized. Pre-production development costs on new mines and any prepaid royalties that may be offset against future royalties due upon extraction of the minerals are also capitalized. All exploration related costs are expensed as incurred.

------

**Reclamation.** We perform ongoing reclamation activities during the normal course of our overburden removal. As overburden is removed from a mine site, it is hauled to previously mined sites and is used to refill older sites. This process allows us to continuously reclaim older mine sites and dispose of overburden simultaneously, therefore minimizing the costs associated with the reclamation process.

On an annual basis we evaluate our potential reclamation liability in accordance with ASC 410, *Asset Retirement and Environmental Obligations.* The reclamation assets are depreciated over the estimated useful lives of the various mines. The reclamation liabilities are increased based on a yearly accretion charge over the estimated useful lives of the mines.

**Leases.** ASC 842, *Leases*, provides that a contract is, or contains, a lease if it conveys the right to control the use of an identified asset and, accordingly, a lease liability and a related right-of-use ("ROU") asset is recognized at the commencement date on our consolidated balance sheet. As provided in ASC 842, we have elected not to apply these measurement and recognition requirements to short-term leases (i.e., leases with a term of 12 months or less). Short-term leases will not be recorded as ROU assets or lease liabilities on our consolidated balance sheet, and the related lease payments will be recognized in net earnings on a straight-line basis over the lease term. For leases other than short-term leases, the lease liability is equal to the present value of unpaid lease payments over the remaining lease term. The lease term may reflect options to extend or terminate the lease when it is reasonably certain that such options will be exercised. To determine the present value of the lease liability, we used an incremental borrowing rate, which is defined as the rate of interest we would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. The ROU asset is based on the corresponding lease liability adjusted for certain costs such as initial direct costs, prepaid lease payments and lease incentives received. Both operating and finance lease ROU assets are reviewed for impairment, consistent with other long-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a ROU asset is impaired, any remaining balance of the ROU asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life. After the lease commencement date, we evaluate lease modifications, if any, that could result in a change in the accounting for leases.

Certain of our leases provide for variable lease payments that vary due to changes in facts and circumstances occurring after the commencement date, other than the passage of time. Variable lease payments that are dependent on an index or rate (e.g., Consumer Price Index) are included in the initial measurement of the lease liability and the ROU asset. Variable lease payments that are not known at the commencement date and are determinable based on the performance or use of the underlying asset, are expensed as incurred. Our variable lease payments primarily include common area maintenance charges based on the percentage of the total square footage leased and the usage of assets, such as photocopiers.

Some of our contracts may contain lease components as well as non-lease components, such as an agreement to purchase services. As allowed under ASC 842, we have elected not to separate the lease components from non-lease components for all asset classes and we will not allocate the contract consideration to these components. This policy was applied to all existing leases upon adoption of ASC 842 and will be applied to new leases on an ongoing basis.

**Revenue Recognition.** We recognize revenue when performance obligations under the terms of the contracts with customers are satisfied. Our performance obligation generally consists of the promise to sell finished products to wholesalers, distributors and retailers or consumers and our obligations have an original duration of one year or less. Control of the finished products are transferred upon shipment to, or receipt at, customers' locations, as determined by the specific terms of the contract. We have completed our performance obligation when control is transferred and we recognize revenue accordingly. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Sales returns are not material nor are warranties and any related obligations.

We have an unconditional right to consideration under the payment terms specified in the contract upon completion of the performance obligation. We may require certain customers to provide payment in advance of product shipment. We recorded a liability for these advance payments of $0.2 million and $0.5 million as of January 31, 2023 and July 31, 2022, respectively. This liability is reported in Other within Accrued Expenses on the unaudited Condensed Consolidated Balance Sheet. Revenue recognized during the six months ended January 31, 2023 that was included in the liability for advance payments at the beginning of the period was $0.1 million.

We routinely commit to one-time or ongoing trade promotion programs directly with consumers, such as coupon programs, and with customers, such as volume discounts, cooperative marketing and other arrangements. We estimate and accrue the expected costs of these programs. These costs are considered variable consideration under ASC 606, *Revenue from Contracts with Customers*, and are netted against sales when revenue is recorded. The accruals are based on our best estimate of the amounts necessary to settle future and existing obligations on products sold as of the balance sheet date. To estimate these accruals, we rely on our historical experience of trade spending patterns and that of the industry, current trends and forecasted data.

------

**Selling, General and Administrative Expenses.** Selling, general and administrative expenses ("SG&A") include salaries, wages and benefits associated with staff outside the manufacturing and distribution functions, all marketing related costs, any miscellaneous trade spending expenses not required to be included in net sales, research and development costs, depreciation and amortization related to assets outside the manufacturing and distribution process and all other non-manufacturing and non-distribution expenses.

**Other Current and Noncurrent Liabilities.** Other liabilities include the accruals for general expenses not yet paid, cash collected not yet vouchered, legal reserves, and reclamation liability accrual. Current liabilities are due to be paid within the next 12 months. Included in current liabilities within Accrued Expenses on the unaudited Condensed Consolidated Balance Sheet is $2.5 million for the Georgia landfill modification reserve as modification efforts are expected to begin in the third quarter of fiscal year 2023, refer to Note 7 for further details.

**2. NEW ACCOUNTING PRONOUNCEMENTS AND REGULATIONS**

**Recently Adopted Accounting Pronouncements**

In March 2020, the FASB issued guidance under ASC 848, *Reference Rate Reform.* This guidance provides optional expedients and exceptions to account for debt, leases, contracts, hedging relationships and other transactions that reference LIBOR or another reference rate if certain criteria are met. The guidance is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. On August 30, 2022 we amended our debt agreements to replace the LIBOR-based reference rate with an adjusted term Secured Overnight Financing Rate (SOFR), ASC 848 will allow us to account for the modification as a continuation of the existing contract without additional analysis.

There have been no other accounting pronouncements issued but not yet adopted by us which are expected to have a material impact on our Consolidated Financial Statements.

**3. INVENTORIES**

The composition of inventories is as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **January 31,<br>2023** | **July 31,<br>2022** |
| Finished goods | $**19071** | $18142 |
| Packaging | **9795** | 9515 |
| Other | **9072** | 7905 |
| Total Inventories | $**37938** | $35562 |

---

Inventories are valued at the lower of cost (first-in, first-out) or net realizable value. Inventory costs include the cost of raw materials, packaging supplies, labor and other overhead costs. The inventory obsolescence reserve was $0.9 million and $0.8 million at January 31, 2023 and July 31, 2022, respectively. Inventories have increased due to a combination of rising costs and building inventory levels for anticipated demand.

**4. FAIR VALUE MEASUREMENTS**

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized into categories based on the lowest level of input that is significant to the fair value measurement. The categories in the fair value hierarchy are as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs for similar assets or liabilities or valuation models whose inputs are observable, directly or indirectly.

Level 3: Unobservable inputs.

Cash equivalents are primarily money market mutual funds classified as Level 1. We had no cash equivalents as of January 31, 2023 and July 31, 2022.

------

Balances of accounts receivable and accounts payable approximated their fair values at January 31, 2023 and July 31, 2022 due to the short maturity and nature of those balances.

Notes payable are reported at the face amount of future maturities. The estimated fair value of notes payable, including current maturities, was $31.2 million and $31.8 million as of January 31, 2023 and July 31, 2022, respectively, and are classified as Level 2. The fair value was estimated using the exit price notion of fair value.

We apply fair value techniques on at least an annual basis associated with: (1) valuing potential impairment loss related to goodwill, trademarks and other indefinite-lived intangible assets and (2) valuing potential impairment loss related to long-lived assets. See Note 5 of the Notes to the unaudited Condensed Consolidated Financial Statements for further information about goodwill and other intangible assets.

**5. GOODWILL AND OTHER INTANGIBLE ASSETS**

Intangible assets, other than goodwill, include trademarks, patents, customer lists and product registrations. Intangible amortization expense was $67 thousand and $138 thousand in the second quarter of fiscal years 2023 and 2022, respectively. Intangible amortization expense was $134 thousand and $253 thousand in the first six months of fiscal years 2023 and 2022, respectively. Estimated intangible amortization for the remainder of fiscal year 2023 is $131 thousand. Estimated intangible amortization for the next five fiscal years is as follows (in thousands):

---

| | |
|:---|:---|
| 2024 | $129.0 |
| 2025 | $104.0 |
| 2026 | $102.0 |
| 2027 | $99.0 |
| 2028 | $94.0 |

---

We have one acquired trademark recorded at a cost of $0.4 million that was determined to have an indefinite life and is not amortized.

We performed our goodwill impairment analysis on our Retail and Wholesale Products Group and Business to Business Products Group reporting units in the third quarter of fiscal year 2022. As a result, we identified goodwill impairment of $5.6 million which left no remaining goodwill in the Retail and Wholesale Products Group reporting unit and no impairment was identified for the Business to Business Products Group.

There have been no triggering events in fiscal year 2023 that would indicate a new impairment analysis is needed.

------

**6. ACCRUED EXPENSES**

Accrued expenses is as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **January 31,<br>2023** | **July 31,<br>2022** |
| Salaries, Wages, Commissions and Employee Benefits | $**13780** | $13439 |
| Freight | **4356** | 4022 |
| Georgia Landfill Modification Reserve | **2500** |  |
| Trade Promotions and Advertising | **1971** | 1180 |
| Real Estate Tax | **317** | 1006 |
| Other | **10861** | 10438 |
|  | $**33785** | $30085 |

---

The change in salaries, wages, commissions and employee benefits relates primarily to the payment of annual bonuses during the first quarter of fiscal year 2023 offset by the increase in labor costs and bonus accrual for the first six months of fiscal year 2023. The increase in freight cost is primarily due to increased fuel prices, export fees and demurrage charges for international ocean freight. Refer to Note 7 for details of the Georgia landfill modification reserve recorded for the first time in the second quarter of fiscal year 2023. Trade promotions and advertising accruals have increased with marketing spend due to timing. Real estate tax decreased due to the timing of payments which typically occur in the second quarter of the fiscal year. Other is higher at January 31, 2023 compared to July 31, 2022 due to an increase in accruals for cash received in advance, account receivable credits, and other accrued expenses due to timing of purchases and rising costs offset by a reduction in professional fees.

**7. OTHER CONTINGENCIES**

We are party to various legal actions from time to time that are ordinary in nature and incidental to the operation of our business, including ongoing litigation. While it is not possible at this time to determine with certainty the ultimate outcome of these or other lawsuits, we believe that none of the pending proceedings will have a material adverse effect on our business, financial condition, results of operations or cash flows. In June 2020, the Company received notice from a former service provider alleging a breach of contract regarding the payment of a contingency fee. Such party subsequently, in July 2020, filed a lawsuit seeking to require the Company to participate in binding mediation regarding this matter. Although we believe this claim to be without merit, as of July 31, 2020, we determined a reasonable estimate of this liability within a range, with no amount within that range being a better estimate than any other amount, and therefore recorded that estimate in Other within Accrued expenses. There have been no changes during fiscal 2022 or the six months ended January 31, 2023 that would have changed this estimate. We believe that any loss related to this matter is unlikely to be material. However, the outcome of this legal matter is subject to significant uncertainties. The ability to predict the ultimate outcome of this legal matter involves judgments, estimates and inherent uncertainties. The actual outcome could differ materially from management's estimates.

In the three months ended January 31, 2023, we recorded a reserve of $2.5 million for anticipated modification costs that we expect to incur to address capacity issues at our sole landfill located in Ochlocknee, Georgia. Reserves are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. The amount of the reserve represents management's best estimate of the costs for the modification with respect to this matter. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards, and emerging technologies for handling site modification. Consequently, it is reasonably possible that modification costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows.

**8. DEBT**

On August 30, 2022, we entered into (i) the Sixth Amendment to Credit Agreement (the "Sixth Amendment"), which amends the Credit Agreement, dated as of January 27, 2006 (as previously amended, the "Credit Agreement"), among us, BMO Harris Bank N.A ("BMO"), and certain of our domestic subsidiaries; and (ii) Amendment No. 3 (the "Third Amendment") to our Amended and Restated Note Purchase and Private Shelf Agreement, dated as of May 15, 2020 (as previously amended, the "Note Agreement"), with PGIM, Inc. ("Prudential") and certain existing noteholders affiliated with Prudential named therein.

------

The Sixth Amendment amended the Credit Agreement to, among other things: extend the facility termination date to August 30, 2027; replace the LIBOR-based reference rate with an adjusted term Secured Overnight Financing Rate ("SOFR"); revise the method for calculating consolidated EBITDA and consolidated debt for purposes of the Credit Agreement; modify certain restrictive covenants, including increasing the unsecured indebtedness basket from $50 million to $75 million; and revise the existing financial covenants by replacing the consolidated debt covenant with a covenant to maintain a maximum debt to earnings ratio, lowering the minimum fixed charge coverage ratio level and revising the method for calculating the fixed charge coverage ratio.

The Third Amendment amended the Note Agreement to, among other things, modify the existing fixed charge coverage financial covenant and replace the existing consolidated debt financial covenant with a maximum debt to earnings ratio and effect certain changes consistent with the Sixth Amendment, including modifying the method for calculating consolidated EBITDA and the excess leverage fee.

**9. LEASES**

We have operating leases primarily for real estate properties, including corporate headquarters, customer service and sales offices, manufacturing and packaging facilities, warehouses, and research and development facilities, as well as for rail tracks, railcars and office equipment. Certain of our leases for a shared warehouse and office facility, rail track and railcars have options to extend which we are reasonably certain we will exercise and, accordingly, have been considered in the lease term used to recognize our ROU assets and lease liabilities. To determine the present value of the lease liability, we use an incremental borrowing rate, which is defined as the rate of interest that the Company would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. Further information about our accounting policy for leases is included in Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements.

We have no material finance leases, and variable costs for operating leases are immaterial for the three and six months ended January 31, 2023. Operating lease costs are included in Cost of Sales or SG&A expenses based on the nature of the lease. The following table summarizes total lease costs for our operating leases (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **2023** | **2022** | **2023** | **2022** |
| **Operating Lease Cost** |  |  |  |  |
| Operating lease cost | $**687** | $718 | $**1383** | $1352 |
| Short-term operating lease cost | **—** | 159 | **1** | 308 |

---

Supplemental cash flow information related to leases was as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **2023** | **2022** | **2023** | **2022** |
| **Other Information** |  |  |  |  |
| Cash paid for amounts included in the measurement of operating lease liabilities: | $**585** | $636 | $**1180** | $1197 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $**—** | $1042 | $**23** | $1283 |

---

We have no new leases in the three months ended January 31, 2023.

Operating lease ROU assets and operating lease liabilities are separately presented on the unaudited Condensed Consolidated Balance Sheet, excluding leases with an initial term of twelve months or less. Other supplemental balance sheet information related to leases was as follows:

---

| | | |
|:---|:---|:---|
| | **January 31, 2023** | **July 31, 2022** |
| &nbsp;&nbsp;&nbsp;**Weighted-average remaining lease term - operating leases** | **7.6 years** | 7.7 years |
| &nbsp;&nbsp;&nbsp;**Weighted-average discount rate - operating leases** | **3.90%** | 3.91% |

---

------

The following table summarizes scheduled minimum future lease payments due within twelve months for operating leases with terms longer than one year for which cash flows are fixed and determinable as of January 31, 2023, (in thousands):

---

| | |
|:---|:---|
| 2024 | $**1180** |
| 2025 | **2052** |
| 2026 | **1919** |
| 2027 | **1629** |
| 2028 | **1214** |
| Thereafter | **4577** |
| Total | **12571** |
| Less: imputed interest | **(1802)** |
| Net lease obligation | $**10769** |

---

**10. PENSION AND OTHER POSTRETIREMENT BENEFITS**

**Pension and Postretirement Health Benefits**

The Oil-Dri Corporation of America Pension Plan ("Pension Plan") is a defined benefit pension plan for eligible salaried and hourly employees. Pension benefits are based on a formula of years of credited service and levels of compensation or stated amounts for each year of credited service. On January 9, 2020, we amended the Pension Plan to freeze participation, all future benefit accruals and accrual of benefit service, including consideration of compensation increases, effective March 1, 2020. Consequently, the Pension Plan is closed to new participants and current participants no longer earn additional benefits on or after March 1, 2020. On September 20, 2022, the Company's Board of Directors approved a resolution to terminate the Company's defined benefit pension plan. The Company expects to complete the termination over a period of eighteen months.

The components of net periodic pension and postretirement health benefit costs were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Pension Benefits** | **Pension Benefits** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **2023** | **2022** | **2023** | **2022** |
| Interest cost | $**338** | $266 | $**673** | $534 |
| Expected return on plan assets | **(558)** | (646) | **(1116)** | (1293) |
| Amortization of: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other actuarial loss | **19** | 35 | **28** | 72 |
| **Net periodic benefit cost** | $**(201)** | $(345) | $**(415)** | $(687) |
|  | **Postretirement Health Benefits** | **Postretirement Health Benefits** | **Postretirement Health Benefits** | **Postretirement Health Benefits** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
|  | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
|  | **2023** | **2022** | **2023** | **2022** |
| Service cost | $**20** | $28 | $**42** | $61 |
| Interest cost | **16** | 13 | **36** | 29 |
| Amortization of: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other actuarial loss | **(23)** |  | **(41)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior service costs | **(1)** | (2) | **(3)** | (3) |
| **Net periodic benefit cost** | $**12** | $39 | $**34** | $87 |

---

The non-service cost components of net periodic benefit cost are included in Other Income (Expense) in the line item Other, net on the unaudited Condensed Consolidated Statements of Income.

------

The Pension Plan is funded based upon actuarially determined contributions that take into account the amount deductible for income tax purposes, the normal cost and the minimum contribution required and the maximum contribution allowed under applicable regulations. We were not required to make, and did not voluntarily make, a contribution to the Pension Plan during the first six months of fiscal year 2023. We have no minimum funding requirements for the remainder of fiscal year 2023.

The postretirement health plan is an unfunded plan. We pay insurance premiums and claims from our assets.

Assumptions used in the previous calculations were as follows:

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Postretirement Health Benefits** | **Postretirement Health Benefits** |
| | **For the Three and Six Months Ended January 31,** | **For the Three and Six Months Ended January 31,** | **For the Three and Six Months Ended January 31,** | **For the Three and Six Months Ended January 31,** |
| | **2023** | **2022** | **2023** | **2022** |
| Discount rate for net periodic benefit cost | **4.05%** | 2.57% | **3.82%** | 2.10% |
| Rate of increase in compensation levels | **— %** | —% | **— %** | —% |
| Long-term expected rate of return on assets | **6.50%** | 6.50% | **— %** | —% |

---

The medical cost trend assumption for postretirement health benefits was 8.50%. The graded trend rate is expected to decrease to an ultimate rate of 4.90% in fiscal year 2044.

**11. OPERATING SEGMENTS**

As a result of a change in management organization during fiscal year 2022 and as part of our routine assessments of our segments, our wholly owned subsidiary located in the United Kingdom (UK) is now included in our Business to Business Products Group and our co-packaged coarse cat litter is now included in the Retail and Wholesale Products Group. Prior year net sales and operating income have also been reclassified to reflect these changes. The organization change was intended to better serve our customers and the segment information presented reflects the information regularly reviewed by our chief operating decision maker.

We have two operating segments: (1) Business to Business Products Group and (2) Retail and Wholesale Products Group. These operating segments are managed separately and each segment's major customers have different characteristics. The Retail and Wholesale Products Group customers include: mass merchandisers; wholesale clubs; drugstore chains; pet specialty retail outlets; dollar stores; retail grocery stores; e-commerce retailers; distributors of industrial cleanup and automotive products; environmental service companies; and sports field product users; and marketers of consumer products. The Business to Business Products Group customers include: processors and refiners of edible oils, petroleum-based oils and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; and distributors of animal health and nutrition products. Our operating segments are also our reportable segments. The accounting policies of the segments are the same as those described in Note 1 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022.

------

Net sales for our principal products by segment are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Business to Business Products Group** | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Retail and Wholesale Products Group** |
| | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| **Product** | **2023** | **2022** | **2023** | **2022** |
| Cat Litter | $**—** | $— | $**110580** | $98468 |
| Industrial and Sports | **—** |  | **20787** | $17940 |
| Agricultural and Horticultural | **19788** | 13519 | **—** |  |
| Bleaching Clay and Fluids Purification | **37241** | 30576 | **—** | $— |
| Animal Health and Nutrition | **11812** | 9167 | **—** |  |
| Net Sales | $**68841** | $53262 | **131367** | $116408 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Business to Business Products Group** | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Retail and Wholesale Products Group** |
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** |
| **Product** | **2023** | **2022** | **2023** | **2022** |
| Cat Litter | $**—** | $— | $**56382** | $49937 |
| Industrial and Sports | **—** |  | **10133** | 8820 |
| Agricultural and Horticultural | **9785** | 7311 | **—** |  |
| Bleaching Clay and Fluids Purification | **19012** | 15555 | **—** |  |
| Animal Health and Nutrition | **6357** | 5587 | **—** |  |
| Net Sales | $**35154** | $28453 | $**66515** | $58757 |

---

We do not rely on any segment asset allocations and we do not consider them meaningful because of the shared nature of our production facilities; however, we have estimated the segment asset allocations below for those assets for which we can reasonably determine. The unallocated asset category is the remainder of our total assets. The asset allocation is estimated and is not a measure used by our chief operating decision maker about allocating resources to the operating segments or in assessing their performance.

---

| | | |
|:---|:---|:---|
| | **Assets** | **Assets** |
| | **January 31, 2023** | **July 31, 2022** |
| | **(in thousands)** | **(in thousands)** |
| Business to Business Products Group | $**83697** | $75644 |
| Retail and Wholesale Products Group | **130443** | 125293 |
| Unallocated Assets | **41904** | 48674 |
| **Total Assets** | $**256044** | $249611 |

---

Net sales and operating income for each segment are provided below. The corporate expenses line includes certain unallocated expenses, including primarily salaries, wages and benefits, purchased services, rent, utilities and depreciation and amortization associated with corporate functions such as research and development, information systems, finance, legal, human resources and customer service. Corporate expenses also include the estimated annual incentive plan bonus accrual for employees. In addition, Income from our Business to Business and Retail and Wholesale Products as well as Corporate Expenses for the three and six months ended January 31, 2022 were adjusted for a change in management organization. See Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **Net Sales** | **Net Sales** | **Income** | **Income** |
| | **2023** | **2022** | **2023** | **2022** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Business to Business Products Group | $**68841** | $53262 | $**14991** | $11962 |
| Retail and Wholesale Products Group | $**131367** | 116408 | $**16256** | 3374 |
| **Net Sales** | $**200208** | $169670 |  |  |
| Corporate Expenses | Corporate Expenses | Corporate Expenses | **(17372)** | (12973) |
| **Income from Operations** | **Income from Operations** | **Income from Operations** | **13875** | 2363 |
| Total Other (Expense) Income, Net | Total Other (Expense) Income, Net | Total Other (Expense) Income, Net | **(2399)** | 717 |
| **Income before Income Taxes** | **Income before Income Taxes** | **Income before Income Taxes** | **11476** | 3080 |
| **Income Tax Expense** | **Income Tax Expense** | **Income Tax Expense** | **(2400)** | (524) |
| **Net Income** | **Net Income** | **Net Income** | **9076** | 2556 |
| **Net Loss Attributable to Noncontrolling Interest** | **Net Loss Attributable to Noncontrolling Interest** | **Net Loss Attributable to Noncontrolling Interest** | **(21)** | (31) |
| **Net Income Attributable to Oil-Dri** | **Net Income Attributable to Oil-Dri** | **Net Income Attributable to Oil-Dri** | $**9097** | $2587 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** | **For the Three Months Ended January 31,** |
| | **Net Sales** | **Net Sales** | **Income** | **Income** |
| | **2023** | **2022** | **2023** | **2022** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Business to Business Products Group | $**35154** | $28453 | $**7734** | $6424 |
| Retail and Wholesale Products Group | **66515** | 58757 | **8682** | 2092 |
| **Net Sales** | $**101669** | $87210 |  |  |
| Corporate Expenses | Corporate Expenses | Corporate Expenses | **(9110)** | (6598) |
| **Income from Operations** | **Income from Operations** | **Income from Operations** | **7306** | 1918 |
| Total Other (Expense) Income, Net | Total Other (Expense) Income, Net | Total Other (Expense) Income, Net | **(2267)** | 452 |
| **Income before Income Taxes** | **Income before Income Taxes** | **Income before Income Taxes** | **5039** | 2370 |
| **Income Tax Expense** | **Income Tax Expense** | **Income Tax Expense** | **(1193)** | (409) |
| **Net Income** | **Net Income** | **Net Income** | **3846** | 1961 |
| **Net Loss Attributable to Noncontrolling Interest** | **Net Loss Attributable to Noncontrolling Interest** | **Net Loss Attributable to Noncontrolling Interest** | **(10)** | (41) |
| **Net Income Attributable to Oil-Dri** | **Net Income Attributable to Oil-Dri** | **Net Income Attributable to Oil-Dri** | $**3856** | $2002 |

---

**12. STOCK-BASED COMPENSATION**

The Oil-Dri Corporation of America 2006 Long Term Incentive Plan, as amended (the "2006 Plan"), permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based and cash-based awards. Our employees and outside directors are eligible to receive grants under the 2006 Plan. The total number of shares of stock subject to grants under the 2006 Plan may not exceed 1,219,500. As of January 31, 2023, there were 229,759 shares available for future grants under this plan.

------

**Restricted Stock**

All of our non-vested restricted stock as of January 31, 2023 was issued under the 2006 Plan with vesting periods generally between one and five years. We determined the fair value of restricted stock as of the grant date. We recognize the related compensation expense over the period from the date of grant to the date the shares vest.

There were 57,000 and 107,000 restricted shares of Common Stock granted during the second quarter of fiscal years 2023 and 2022, respectively. Stock-based compensation expense was $1.6 million and $1.5 million for the second quarter of fiscal years 2023 and 2022, respectively.

A summary of restricted stock transactions is shown below:

---

| | | |
|:---|:---|:---|
| | **Restricted Shares<br>(in thousands)** | **Weighted Average Grant Date Fair Value** |
| Non-vested restricted stock outstanding at July 31, 2022 | 382 | $33.63 |
| Granted | 57 | $28.53 |
| Vested | (69) | $35.16 |
| Forfeitures | (7) | $32.19 |
| Non-vested restricted stock outstanding at January 31, 2023 | 363 | $32.57 |

---

**13. ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME**

The following table summarizes the changes in accumulated other comprehensive (loss) income by component as of January 31, 2023 (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Pension and Postretirement Health Benefits** | **Cumulative Translation Adjustment** | **Total Accumulated Other Comprehensive (Loss) Income** |
| Balance as of July 31, 2022 | $(2242) | $59 | $(2183) |
| Other comprehensive loss before reclassifications, net of tax |  | (129) | (129) |
| Amounts reclassified from accumulated other comprehensive income, net of tax | (13) |  | (13) |
| Net current-period other comprehensive loss, net of tax | (13) | (129) | (142) |
| Balance as of January 31, 2023 | $(2255) | $(70) | $(2325) |

---

**14. RELATED PARTY TRANSACTIONS**

One member of our Board of Directors (the "Board") retired from the role of President and Chief Executive Officer of a customer of ours in September 2019 and is currently party to a post-employment agreement with the customer. Total net sales to that customer, including sales to subsidiaries of that customer, were $71,768 and 81,210 for the second quarter of fiscal years 2023 and 2022 respectively and were $126,926 and $156,476 for the first six months of fiscal years 2023 and 2022 respectively. Outstanding accounts receivable from that customer, and its subsidiaries, were $8,661 as of January 31, 2023 and $5,608 as of July 31, 2022.

One member of our Board is currently the President and Chief Executive Officer of a vendor of ours. Total payments to this vendor for fees and cost reimbursements were $49,916 and $349,773 for the second quarter of fiscal years 2023 and 2022 respectively and were $112,276 and $565,191 for the first six months of fiscal years 2023 and 2022 respectively. There were no outstanding accounts payable to that vendor as of January 31, 2023 or July 31, 2022.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*The following discussion and analysis of our financial condition and results of operations should be read together with the financial statements and the related notes included herein and our Consolidated Financial Statements, accompanying notes and Management's Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed under "Forward-Looking Statements" and Item 1A, Risk Factors of our Annual Report on Form 10-K for the fiscal year ended July 31, 2022.*

**<u>OVERVIEW</u>**

We develop, mine, manufacture and market sorbent products principally produced from clay minerals, primarily consisting of calcium bentonite, attapulgite and diatomaceous shale. Our principal products include agricultural and horticultural chemical carriers, animal health and nutrition products, cat litter, fluid purification and filtration bleaching clays, industrial and automotive floor absorbents and sports field products. Our products are sold to two primary customer groups, including customers who resell our products as originally produced to the end consumer and other customers who use our products as part of their production process or use them as an ingredient in their final finished product. We have two reportable operating segments based on the different characteristics of our two primary customer groups: the Retail and Wholesale Products Group and the Business to Business Products Group, as described in Note 11 of the Notes to the unaudited Condensed Consolidated Financial Statements. Each operating segment is discussed individually below.

**<u>RESULTS OF OPERATIONS</u>**

OVERVIEW

Consolidated net sales were at an all-time high in the second quarter and first six months of fiscal year 2023 as we continued to implement strategic price increases across multiple principal products in order to improve profitability in both the Retail and Wholesale Products Group and the Business to Business Products Group. Consolidated net sales increased approximately $14.5 million or 17% in the second quarter of fiscal year 2023 and $30.5 million or 18% for the first six months of fiscal year 2023 compared to the same periods of fiscal year 2022. Consolidated income from operations in the second quarter and first six months of fiscal year 2023 increased by $5.4 million and $11.5 million, respectively compared to the same periods in fiscal year 2022.

Although expenses continued to increase, consolidated net income for the three and six months ended January 31, 2023, were $3.9 million and $9.1 million, respectively, compared to $2.0 million and $2.6 million in the three and six months ended January 31, 2022, respectively.

In the second quarter we recorded a $2.5 million reserve for anticipated modification costs that we expect to incur to address the capacity issues at our sole landfill located in Ochlocknee, Georgia. Refer to Note 7 to the Financial Statements for additional details.

Our Consolidated Balance Sheets as of January 31, 2023, and our Consolidated Statements of Cash Flows for the second quarter of fiscal year 2023 show a decrease in total cash and cash equivalents from fiscal year-end 2022. The decrease is driven by capital expenditures on property, plant & equipment and an increase in accounts receivables and inventories, offset by improved net income and increased accrued expenses. Refer to the "Liquidity and Capital Resources" section below for more analysis of the movements in cash.

**<u>SIX MONTHS ENDED JANUARY 31, 2023 COMPARED TO</u>**

**<u>SIX MONTHS ENDED JANUARY 31, 2022</u>**

CONSOLIDATED RESULTS

Consolidated net sales for the six months ended January 31, 2023, were $200.2 million, a 18% increase compared to net sales of $169.7 million for the six months ended January 31, 2022. Net sales increased for both our Retail and Wholesale Products Group and Business to Business Products Group, primarily due to price increases implemented across both product groups.

------

In the first six months of fiscal year 2023, we have been able to reduce our backlog of orders. The actions taken to increase personnel, expand production shifts, increase production equipment, repair equipment, and utilize alternative modes of transportation have driven a reduction of our backlog by $0.9 million, a 13% decrease from July 31, 2022. In order to meet the increase in customer demand, we continue to implement strategies to further reduce labor, manufacturing and freight constraints. Segment results are discussed further below.

Consolidated gross profit for the first six months of fiscal year 2023 was $45.3 million, or 23% of net sales, compared to $29.4 million, or 17%, of net sales, for the first six months of fiscal year 2022. The increase is driven by higher selling prices across multiple products thus helping to mitigate the increases in costs of goods sold. Our domestic costs of goods sold per ton increased 12%, driven primarily by per ton increases in natural gas, non-fuel manufacturing and freight costs, offset by lower per ton packaging costs. The cost of natural gas per ton used to operate kilns that dry our clay was 47% higher in the first six months of fiscal year 2023 compared to the first six months of fiscal year 2022. There was also a 20% increase in per ton non-fuel manufacturing costs during the first six months of fiscal year 2023 compared to the first six months of fiscal year 2022, due to higher per ton costs for labor, repairs, purchased materials, electricity, depreciation, and diesel. Domestic freight costs per ton increased approximately 15% in the first six months of fiscal year 2023 compared to the same period of fiscal year 2022. This excludes the impact of a significant customer in our cat litter business that altered shipping terms in January 2023 from collect to delivered which further increased our overall freight cost. Ocean freight costs have also increased due to rising fuel prices, export fees, and demurrage charges. In addition, our overall freight costs can vary between periods depending on the mix of products sold and the geographic distribution of our customers. Packaging costs per ton decreased by approximately 3% in the first six months of fiscal year 2023 compared to the first six months of fiscal year 2023 due to lower commodity costs, particularly as it relates to resin and pallet costs. Many of our contracts for packaging purchases are subject to periodic price adjustments, which trail changes in underlying commodity prices.

Total selling, general and administrative expenses of $31.5 million for the first six months of fiscal year 2023 were higher by $4.4 million, or 16%, compared to $27.0 million for the first six months of fiscal year 2022. Unallocated corporate expenses were higher by $4.4 million, or 34%, driven by higher bonus accrual due to improved quarterly results compared to the Company's performance target under the annual incentive plan as well as an increase in compensation and outside services to support strategic initiatives. The discussion of the segments' operating incomes below describes the changes in SG&A expenses that were allocated to the operating segments.

Total other (expense) income, net of $(2.4) million for the first six months of fiscal year 2023 compared to a net other income of $0.7 million in the same period of fiscal year 2022. This was mostly due to the $2.5 million reserve recorded for anticipated modification costs to address the landfill capacity issue.

Consolidated net income before taxes for the first six months of fiscal year 2023 was $11.5 million compared to $3.1 million for the first six months of fiscal year 2022. Results for the first six months of fiscal year 2023 were driven by the factors discussed above.

We had a tax expense for the first six months of fiscal year 2023 of $2.4 million compared to $0.5 million for the first six months of fiscal year 2022. Our tax expense was driven primarily by higher net income. We used an estimated annual effective tax rate ("ETR") of 21% in determining our provision for income taxes, which is based on expected annual taxable income and the assessment of various tax deductions, including depletion.

BUSINESS TO BUSINESS PRODUCTS GROUP

Net sales of the Business to Business Products Group for the first six months of fiscal year 2023 were $68.8 million, an increase of $15.5 million, or 29%, from net sales of $53.3 million for the first six months of fiscal year 2022, with increases across all three of our businesses in this group. Net sales of our fluids purification products increased approximately $6.7 million, or 22%, compared to the first six months of the prior fiscal year. The increase in net sales was driven by price increases across all regions and continued demand for our products used in the filtration of edible oil, renewable diesel, and jet fuel. Net sales increased in all regions with most of the increase driven by sales in North America when compared to the first half of fiscal year 2022. Net sales of our agricultural and horticultural chemical carrier products increased approximately $6.3 million, or 46%, for the first half of fiscal year 2023 compared to the same period in fiscal year 2022. This is a result of quarterly price increases implemented throughout the year. Net sales of our animal health and nutrition products increased $2.6 million, or 29%, during the first half of fiscal year 2023 compared to the first half of fiscal year 2022. We saw growth in net sales in all regions except Asia and our subsidiary in China, with the most impact coming from Latin America. Latin American sales benefited from the European Union's ("EU") regulations requiring antibiotic-free foreign protein imports, as a large percentage of meat is exported from that region to the EU. North American sales rose due to a new product line and increased distribution. The decrease in

------

Asia sales is due to timing and ocean freight delays and not indicative of projected sales for the year. Net sales of our subsidiary in China decreased period over period, as discussed in the "Foreign Operations" section below.

SG&A expenses for the Business to Business Products Group increased approximately 11% or $0.8 million for the first half of fiscal year 2023 compared to the same period of the prior fiscal year. The majority of the increase relates to research and development expenses that are now allocated to the animal health business (a change in where existing costs were allocated), previously included in unallocated corporate expenses and increased travel costs.

The Business to Business Products Group's operating income for the first six months of fiscal year 2023 was $15.0 million, an increase of $3.0 million, or 25%, from operating income of $12.0 million for the first six months of fiscal year 2022. The increase in operating income was mostly driven by higher net sales across all business within this segment.

RETAIL AND WHOLESALE PRODUCTS GROUP

Net sales of the Retail and Wholesale Products Group for the first half of fiscal year 2023 were $131.4 million, an increase of $15.0 million, or 13%, from net sales of $116.4 million for the first half of fiscal year 2022 driven by higher net sales of cat litter, industrial and sport products, slightly offset by a decline in our co-packaged cat litter business. Total global cat litter net sales were higher by approximately $12.1 million, or 12% compared to the first six months of fiscal year 2022 driven mostly by price increases. Domestic cat litter net sales were $95.8 million an increase of $11.2 million from the first half of fiscal year 2022 driven primarily by price increases. Increased sales of branded and private label lightweight and coarse litter were partially offset by a decrease in revenue for private label heavy weight litter. Net sales of co-packaged products decreased by approximately $0.5 million compared to the same period in fiscal year 2022. This decrease was primarily driven by our customer discontinuing export sales to one of their foreign subsidiaries as well as softer domestic sales volumes. Net sales of cat litter by our subsidiary in Canada increased period over period, as discussed in "Foreign Operations" below. Net sales of our global industrial and sports products increased approximately $2.8 million, or 16%, compared to the first six months of fiscal year 2022, primarily driven by price increases implemented to rebuild margins, and to a lesser extent from higher volumes.

SG&A expenses for the Retail and Wholesale Products Group were lower by approximately $1.1 million, or 14%, during the first half of fiscal year 2023 compared to the first half of fiscal year 2022, primarily due to the timing of marketing and advertising costs. These decreases were partially offset by higher broker sales commissions which are percentage based on net sales, and an increase in our allowance for doubtful accounts due to one customer declaring bankruptcy. We anticipate total advertising expense in fiscal year 2023 to be higher than fiscal year 2022, with a majority of the spend concentrated in the second half of the fiscal year.

The Retail and Wholesale Products Group experienced an operating income for the first half of fiscal year 2023 of $16.3 million, an increase of $12.9 million, or 380%, from operating income of $3.4 million for the first half of fiscal year 2022. This was driven primarily by the increase in gross margins due to selling price increases partially offset by higher costs of goods sold, and to a much lesser extent lower than expected advertising spend in the first quarter.

FOREIGN OPERATIONS

Foreign operations include our subsidiary in Canada which is reported in the Retail and Wholesale Products Group, and our subsidiaries in the UK, Mexico, China and Indonesia, which are reported in the Business to Business Products Group. Net sales by our foreign subsidiaries during the first six months of fiscal year 2023 were $11.2 million, an increase of $1.6 million, or 17%, compared to net sales of $9.6 million during the first half of fiscal year 2022. All of our foreign operations, with the exception of our subsidiary in China, experienced an increase in net sales during the half of fiscal year 2023 compared to fiscal year 2022. Total net sales of our subsidiary in Canada during this period increased by $1.3 million, or 22%, compared to the same period in fiscal year 2022 driven by higher private label cat litter net sales offset by a decrease of $0.1 million in net sales of industrial products. The increase in cat litter sales of $1.4 million was driven primarily by price increases instituted in response to rising costs and to a lesser extent by increases in demand. Net sales of our subsidiary in the United Kingdom in the first six months of fiscal year 2023 increased by $0.2 million, or 18%, compared to net sales in the first six months of fiscal year 2022. The increase is driven primarily by price increases which offset the impact of softer sale volumes. Net sales of our subsidiary in Mexico increased during the first six months of fiscal year 2023 compared to the same period of fiscal year 2022 by $0.5 million, or 48% due to growing demand for our animal health products. Net sales of our subsidiary in China decreased $0.4 million, or 22%, during the first half of fiscal year 2023 compared to the first half of fiscal year 2022 primarily due to a transition in our distribution strategy. Net sales by our foreign subsidiaries represented 6% of our consolidated net sales during both the first six months of fiscal year 2023 and 2022.

------

Our foreign subsidiaries reported net income of $0.6 million for the first six months of fiscal year 2023, compared to a net loss of $0.7 million for the first six months of fiscal year 2022. The net income in the first six months of fiscal year 2023 was driven by price increases in Canada and the UK, increased sales volume in Mexico, and reduction of costs of goods sold in China and Indonesia.

Identifiable assets of our foreign subsidiaries as of January 31, 2023, were $14.9 million, compared to $13.0 million as of July 31, 2022.

**<u>THREE MONTHS ENDED JANUARY 31, 2023 COMPARED TO</u>**

**<u>THREE MONTHS ENDED JANUARY 31, 2022</u>**

CONSOLIDATED RESULTS

Consolidated net sales for the three months ended January 31, 2023, were $101.7 million, a 17% increase compared to net sales of $87.2 million for the three months ended January 31, 2022. Net sales increased for both our Retail and Wholesale Products Group and Business to Business Products Group, primarily due to price increases implemented across both product groups.

The actions taken to increase personnel, expand our production shifts, increase production equipment, make various repairs to equipment, and utilize alternative modes of transportation have driven a reduction of our backlog when compared to prior year. See discussion above in "Results from Operations - Six Months Ended January 31, 2023, compared to Six Months ended January 31, 2022" for more detail on backlog. Segment results are discussed below.

Consolidated gross profit for the three months ended January 31, 2023, was $23.0 million, or 23% of net sales, compared to $15.6 million, or 18%, of net sales, for the three months ended January 31, 2022. The increase is driven by higher selling prices across multiple products thus helping to mitigate the increases in costs of goods sold. Domestic costs of goods sold per ton rose by 18%, driven primarily by per ton increases in non-fuel manufacturing, freight and natural gas costs. The cost of natural gas per ton used to operate kilns that dry our clay was 9% higher in the second quarter of fiscal year 2023 compared to the second quarter of fiscal year 2022. Per ton non-fuel manufacturing costs rose 28% in the second quarter of fiscal year 2023 compared to the second quarter of fiscal year 2022, due to higher costs for labor, repairs, purchased materials, depreciation, electricity, and diesel. Domestic freight costs per ton increased approximately 17% in the second quarter of fiscal year 2023 compared to the same period of fiscal year 2022. This excludes the impact of a significant customer in our cat litter business that altered shipping terms in January 2023 from collect to delivered which further increased our overall freight cost. Ocean freight costs have also increased due to rising fuel costs, export fees, and demurrage charges. In addition, our overall freight costs can vary between periods depending on the mix of products sold and the geographic distribution of our customers. Packaging costs per ton remained flat in the three months ended January 31, 2023, when compared to the same period of fiscal year 2022. Many of our contracts for packaging purchases are subject to periodic price adjustments, which trail changes in underlying commodity prices.

Total selling, general and administrative expenses of $15.0 million for the three months ended January 31, 2023, were higher by $2.0 million, or 15%, compared to $13.0 million for the same period of fiscal year 2022. Unallocated corporate expenses were higher by $2.5 million, or 38%, driven by higher bonus accrual due to improved quarterly results compared to the Company's performance target under the annual incentive plan, an increase in compensation and outside services to support strategic initiatives. The discussion of the segments' operating incomes below describes the changes in SG&A expenses that were allocated to the operating segments.

Total other (expense) income, net of $(2.3) million for the three months ended January 31, 2023, decreased compared to net other income of $0.5 million in the same period of fiscal year 2022. This was mostly driven by the reserve recorded for the Georgia landfill modification offset by the impact of foreign currency translation gains. Refer above to Results of Operations – Overview section of Management's Discussion and Analysis as well as Note 7 to the Financial Statements for additional details of the Georgia landfill modification reserve.

Consolidated net income before taxes for the three months ended January 31, 2023, was $5.0 million compared to $2.4 million for the same period of fiscal year 2022. Results for the second quarter of fiscal year 2023 were driven by the factors discussed above.

We had a tax expense for the second quarter of fiscal year 2023 of $1.2 million compared to $0.4 million for the second quarter of fiscal year 2022. Our tax expense was driven primarily by higher net income. We used an estimated annual ETR of 21% in both periods in determining our provision for income taxes, which is based on expected annual taxable income and the assessment of various tax deductions, including depletion.

------

BUSINESS TO BUSINESS PRODUCTS GROUP

Net sales of the Business to Business Products Group for the three months ended January 31, 2023, were $35.2 million, an increase of $6.7 million, or 24%, from net sales of $28.5 million for the three months ended January 31, 2022, with increases across all three of our businesses in this group. Net sales of our fluids purification products increased approximately $3.5 million, or 22%, compared to the second quarter of fiscal year 2022. The increase in net sales was driven by price increases implemented across all regions. Net sales increased in all regions, with most of the increase driven by North America and the region including Europe, Middle East, and Africa when compared to the three months ended January 31, 2022. Net sales of our agricultural and horticultural chemical carrier products increased approximately $2.5 million, or 34%, for the three months ended January 31, 2023, compared to the same period in fiscal year 2022. This is a result of quarterly price increases implemented throughout the year. Net sales of our animal health and nutrition products increased $0.8 million, or 14%, during the three months ended January 31, 2023, compared to the same period in fiscal year 2022. The growth was driven by North America, Latin America, Asia (excluding China), and Mexico, offset by a decrease in sales in China. North American sales rose due to a strategic focus on this region, several significant new customers, and new product line. In Latin America a shift in product mix and price increases resulted in higher net sales, while the increase in Mexico was driven by higher sales volumes compared to prior year. Net sales of our subsidiary in China decreased period over period, as discussed in the "Foreign Operations" section below.

Total SG&A expenses for the Business to Business Products Group in the three months ended January 31, 2023 remained flat compared to the same period of fiscal year 2022.

The Business to Business Products Group's operating income for the three months ended January 31, 2023, was $7.7 million, an increase of $1.3 million, or 20%, from operating income of $6.4 million for the three months ended January 31, 2022. The overall increase in operating income was driven primarily by higher net sales due to continued strategic price increases.

RETAIL AND WHOLESALE PRODUCTS GROUP

Net sales of the Retail and Wholesale Products Group for the three months ended January 31, 2023, were $66.5 million, an increase of $7.8 million, or 13%, from net sales of $58.8 million for the three months ended January 31, 2022, driven by higher net sales of cat litter, industrial and sports products, offset by a decline in our co-packaged cat litter business. Global cat litter net sales were higher by approximately $6.4 million, or 13%, compared to the second quarter of fiscal year 2022 driven by price increases. Domestic cat litter net sales were $49.0 million an increase of $6.1 million driven primarily by price increases. Increased sales of lightweight (branded and private label) and coarse litter were partially offset by a decrease in net sales of private label heavy weight litter, and modest, category wide, elasticity impacts from price increases. Net sales of co-packaged products decreased by approximately $0.2 million compared to the same period in fiscal year 2022. This decrease was primarily due to our customer discontinuing export sales to one of their foreign subsidiaries. Net sales of cat litter by our subsidiary in Canada increased period over period, as discussed in "Foreign Operations" below. Net sales of our global industrial and sports products increased approximately $1.3 million, or 15%, compared to the three months ended January 31, 2022, primarily driven by price increases implemented to rebuild margins, and to a lesser extent from higher volumes.

SG&A expenses for the Retail and Wholesale Products Group were lower by approximately $0.6 million, or 16%, during the three months ended January 31, 2023, compared to the same period in fiscal year 2022. The decrease was primarily due to timing of SG&A spend, offset by an increase in our allowance for doubtful accounts due to a customer declaring bankruptcy. Advertising costs in the second quarter of fiscal year 2023 were flat when compared with prior year second quarter. We anticipate total advertising expense in fiscal year 2023 to be higher than fiscal year 2022 and more in line with historical levels, with spending concentrated in the second half of the year.

The Retail and Wholesale Products Group experienced an operating income of $8.7 for the second quarter of fiscal year 2023, an increase of $6.5 million, or 315%, from operating income of $2.1 million for the same period of fiscal year 2022. This was driven primarily by the increase in gross margins due to selling price increases partially offset by higher costs of goods sold.

------

FOREIGN OPERATIONS

Foreign operations include our subsidiary in Canada which is reported in the Retail and Wholesale Products Group, and our subsidiaries in the UK, Mexico, China and Indonesia, which are reported in the Business to Business Products Group. Net sales by our foreign subsidiaries during the three months ending January 31, 2023 were $5.5 million, an increase of $0.2 million, or 4%, compared to net sales of $5.3 million during the same period of fiscal year 2022 which was driven by increases in net sales in Canada, UK and Mexico offset by reduction in net sales in China and Indonesia. Total net sales of our subsidiary in Canada increased by $0.4 million, or 15%, in the three months ended January 31, 2023, compared to the same period in fiscal year 2022 driven by higher private label cat litter sales. The increase in cat litter sales was mainly driven by price increases instituted in response to rising costs as well as from higher demand. Net sales of industrial products decreased by $0.1 million compared to second quarter of fiscal year 2022. Net sales of our subsidiary in the United Kingdom in the three months ended January 31, 2023, increased by $0.2 million, or 45%, compared to net sales in the three months ended January 31, 2022. The increase primarily relates to prices increases. Net sales of our subsidiary in Mexico increased during the second quarter of fiscal year 2023 compared to the second quarter of fiscal year 2022 by $0.3 million, or 60% due to growing demand of our animal health products. Net sales of our subsidiary in China decreased $0.7 million, or 56%, during the second quarter of fiscal year 2023 compared to the second quarter of fiscal year 2022 primarily due to a transition in our distribution strategy. Net sales by our foreign subsidiaries represented 5% and 6% of our consolidated net sales during the second quarter of fiscal years 2023 and 2022, respectively.

Our foreign subsidiaries reported net income of $0.1 million for the three months ended January 31, 2023, compared to a net loss of $0.4 million for the three months ended January 31, 2022. The increase in net income was driven by price increases in Canada and UK, increased sales in Mexico, and a reduction of costs in Indonesia offset by a reduction in net sales in China.

Identifiable assets of our foreign subsidiaries as of January 31, 2023, were $19.3 million, compared to $17.4 million as of July 31, 2022.

**<u>LIQUIDITY AND CAPITAL RESOURCES</u>**

Our principal liquidity needs are to fund our capital requirements, including funding working capital needs; purchasing and upgrading equipment, facilities (including significant renovations at one of our plants), information systems, and real estate; supporting new product development; investing in infrastructure; repurchasing stock; paying dividends; making pension contributions; and, from time to time, business acquisitions, and funding our debt service requirements. During the first six months of fiscal year 2023, we principally funded these short and long-term capital requirements using cash from current operations as well as cash generated in fiscal year 2022 from borrowings under our Series Senior C Notes.

We currently anticipate cash flows from operations and our available sources of liquidity will be sufficient to meet our cash requirements. In addition, we are actively monitoring the timing and collection of our accounts receivable.

The following table sets forth certain elements of our unaudited Condensed Consolidated Statements of Cash Flows (in thousands):

---

| | | |
|:---|:---|:---|
| | **For the Six Months Ended January 31,** | **For the Six Months Ended January 31,** |
| | **2023** | **2022** |
| Net cash provided by (used in) operating activities | $**14898** | $61 |
| Net cash used in investing activities | **(13280)** | (10574) |
| Net cash (used in) provided by financing activities | **(3936)** | 14957 |
| Effect of exchange rate changes on cash and cash equivalents | **(29)** | (26) |
| Net decrease in cash and cash equivalents | $**(2347)** | $4418 |

---

*Net cash provided by operating activities*

In addition to net income, as adjusted for depreciation and amortization and other non-cash operating activities, the primary sources and uses of operating cash flows for the first six months of fiscal years 2023 and 2022 were as follows:

------

Accounts receivable, less allowance for doubtful accounts, increased $5.7 million in the first six months of fiscal year 2023 compared to an increase of $5.0 million in the first six months of fiscal year 2022. The increase in accounts receivable was driven primarily by higher net sales as sales prices increased offset by the level and timing of collections due to payment terms.

Inventory increased by $2.4 million in the first six months of both fiscal year 2023 compared to $6.2 million in the first six months of 2022 due to a combination of rising costs, specifically due to natural gas, purchased materials, electricity, repairs, diesel, and freight and the building of inventory levels for anticipated seasonal demand and thwart potential supply chain disruptions.

Other assets decreased by $2.0 million in the first six months of fiscal year 2023 compared to a decrease of $0.6 million in the first six months of fiscal year 2022. The decrease in other assets in the first six months of fiscal year 2023 relates mostly to capitalized pre-production costs being transferred to property, plant and equipment as the mines are now in production.

Accounts payable increased by $0.2 million in the first six months of fiscal year 2023 compared to an increase of $1.3 million in the first six months of fiscal year 2022. Trade and freight payables vary in both periods due to the timing of payments, higher cost of goods and services we purchased, production volume levels and vendor payment terms.

Accrued expenses increased $3.9 million in the first six months of fiscal year 2023 compared to a decrease of $1.6 million in the first six months of fiscal year 2022. The majority of this increase is driven by the $2.5 million reserve added in the second quarter for the Georgia landfill modification as well as higher compensation related expenses accrued for in fiscal year 2023 compared to fiscal year 2022. The increases were offset by the payout of the prior fiscal year's bonus which reduced accrued compensation in both fiscal years, but to a greater extent in fiscal year 2023 as the accrual was higher at year end 2022 than the prior fiscal year. The increase in accrued expenses is also impacted by the decrease in advertising expenses and other accruals that vary based on timing. In addition, accrued plant expenses can also fluctuate due to timing of payments, changes in the cost of goods and services we purchase, production volume levels and vendor payment terms. The decrease in accrued expenses for the first six months of fiscal year 2022 was driven by the payout of the bonuses and real estate taxes offset by higher accrued utilities due to the rising cost of natural gas, higher accrued advertising due to the timing of our advertising programs, and additional accrued capital projects.

Other liabilities decreased by $0.9 million in the first six months of fiscal year 2023 and $1.0 million for the same period in fiscal year 2022. The decreases in both fiscal years 2023 and 2022 relate primarily to a reduction in the operating lease liability.

*Net cash used in investing activities*

Cash used in investing activities of $13.3 million in the first six months of fiscal year 2023 were higher compared to cash used in investing activities of $10.6 million in the first six months of fiscal year 2022 driven by capital expenditures. During the first six months of fiscal year 2023 we expanded our plant equipment and improved our facilities to support increased demand for our products as well as made improvements to our IT network.

*Net cash used in financing activities*

Cash used in financing activities of $3.9 million in the first six months of fiscal year 2023 compared to cash provided by financing activities of $15.0 million in the first six months of fiscal year 2022. The decrease is driven by less share repurchases and no additional note issuances in the current year compared to the second quarter of fiscal year 2022. Cash provided by financing activities in the first six months of fiscal year 2022 was primarily driven by the issuance of a $25.0 million note offset by treasury stock repurchases and dividend payments.

*Other*

Total cash balances held by our foreign subsidiaries of $3.4 million as of January 31, 2023, remained relatively flat compared to $3.3 million as of July 31, 2022. See further discussion in "Foreign Operations" above.

------

We are party to a credit agreement (as amended, the "Credit Agreement") with BMO Harris Bank N.A. ("BMO Harris"), which terminates on August 30, 2027. The agreement provides for a $45 million unsecured revolving credit facility and a maximum of $10 million for letters of credit. The agreement terms also state that we may select a variable interest rate based on either the BMO Harris prime rate or an adjusted SOFR-based rate, plus a margin that varies depending on our debt to earnings ratio, or a fixed rate as agreed between us and BMO Harris. As of January 31, 2023, the variable rates would have been 7.50% for the BMO Harris prime-based rate or 4.69% for the adjusted SOFR-based rate. The Credit Agreement contains restrictive covenants that, among other things and under various conditions, limit our ability to incur additional indebtedness or to dispose of assets. The agreement also requires us to maintain a minimum fixed charge coverage ratio and a maximum net debt to earnings ratio. As of January 31, 2023 and 2022, we were in compliance with the covenants. There were no borrowings during the first six months of either fiscal year 2023 or 2022.

We are party to an Amended and Restated Note Purchase and Private Shelf Agreement (as amended, the "Note Agreement") with PGIM, Inc. ("Prudential") and certain existing noteholders and purchasers affiliated with Prudential named therein pursuant to which, among other things, we issued $10 million in aggregate principal amount of our 3.95% Series B Senior Notes due May 15, 2030 of which $8 million aggregate principal amount remained outstanding as of January 31, 2023. The Note Agreement provides us with the ability to request, from time to time until May 15, 2023 (or such earlier date as provided for in the agreement), the issuance of additional senior unsecured notes in an aggregate principal amount of up to $75 million minus the aggregate principal amount of the notes then outstanding and the additional notes that have been accepted for purchase. The issuance of such additional notes is at the discretion of the noteholders and purchasers and on an uncommitted basis. Pursuant to the Note Agreement, on December 16, 2021, we issued $25 million in aggregate principal amount of our 3.25% Series C Senior Notes due December 16, 2031. As of January 31, 2023 outstanding notes payable totaled $31.8 million, net of $0.2 million of unamortized debt issuance costs.

See Note 8 of the Notes to the unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for discussion on amendments made to the credit agreement with BMO Harris and our Senior Note Agreements.

As of January 31, 2023, we had remaining authority to repurchase 429,033 shares of Common Stock and 273,100 shares of Class B Stock under a repurchase plan approved by our Board of Directors (the "Board"). Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by our management pursuant to the repurchase plan approved by our Board.

We believe that cash flow from operations, availability under our revolving credit facility, current cash and investment balances and our ability to obtain other financing, if necessary, will provide sufficient liquidity for foreseeable working capital needs, capital expenditures at existing facilities, deferred compensation payouts, dividend payments and debt service obligations for at least the next 12 months. We expect capital expenditures in fiscal year 2023 to be greater than in fiscal year 2022. We do not believe that these increased capital expenditures will dramatically impact our cash position; however our cash requirements are subject to change as business conditions warrant and opportunities arise. Our anticipated advertising expense for fiscal year 2023 is expected to be higher compared to fiscal year 2022 and in line with historical pre-pandemic levels.

We continually evaluate our liquidity position and anticipated cash needs, as well as the financing options available to obtain additional cash reserves. Our ability to fund operations, to make planned capital expenditures, to make scheduled debt payments, to contribute to our pension plan and to remain in compliance with all financial covenants under debt agreements, including, but not limited to, the current credit agreement, depends on our future operating performance, which, in turn, is subject to prevailing economic conditions and to financial, business and other factors. The timing and size of any new business ventures or acquisitions that we complete may also impact our cash requirements.

**<u>CRITICAL ACCOUNTING POLICIES AND ESTIMATES</u>**

This discussion and analysis of financial condition and results of operations is based on our unaudited Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. GAAP for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates and assumptions are revised periodically. Actual results could differ from these estimates. See the information concerning our critical accounting policies included under "Management's Discussion of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022.

------

**ITEM 4. CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures**

Management conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of the end of the period covered by this Quarterly Report on Form 10-Q. The controls evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"). Based upon the controls evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

**Changes in Internal Control over Financial Reporting**

We have not experienced any material impact to our internal controls over financial reporting despite the fact that many of our employees are still working remotely. We are continually monitoring and assessing the effects of a hybrid work model on our internal controls to minimize the impact to their design and operating effectiveness.

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the fiscal quarter ended January 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Inherent Limitations on Effectiveness of Controls**

Our management, including the CEO and CFO, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

**PART II – OTHER INFORMATION**

Items 1, 3 and 5 of this Part II are either inapplicable or are answered in the negative and are omitted pursuant to the instructions to Part II.

**ITEM 1A. RISK FACTORS**

The Company's operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended July 31, 2022. There have been no material changes to our risk factors since the Company's Annual Report on Form 10-K for the year ended July 31, 2022.

------

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

During the three months ended January 31, 2023, we did not sell any securities which were not registered under the Securities Act of 1933. The following chart summarize our Common Stock and Class B stock purchases during this period. There are no shares of our Class A Common Stock currently outstanding.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> |
|<br>**For the Three Months Ended January 31, 2023** | **(a)**<br>**Total Number of Shares Purchased**<sup>3</sup> | **(b)**<br>**Average Price Paid per Share** | **(c)**<br>**Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs** | **(d)**<br>**Maximum Number of Shares that may yet be Purchased Under Plans or Programs**<sup>4</sup> |
| **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** |
| November 1, 2022 to November 30, 2022 |  | $— |  | 433166 |
| December 1, 2022 to December 31, 2022 | 4133 | $32.34 |  | 429033 |
| January 1, 2023 to January 31, 2023 |  | $— |  | 429033 |

---

<sup>1</sup> The table summarizes repurchases of (and remaining authority to repurchase) shares of our Common Stock. Our Board of Directors authorized the repurchase of 300,000 shares of Class B Stock on March 21, 2018, however there have been no repurchases of Class B Stock for the three months ended January 31, 2023, and the authorized Class B Stock is not included in the table above. No shares of our Class A Common Stock are currently outstanding. Descriptions of our Common Stock, Class B Stock and Class A Common Stock are contained in Exhibit 4.1 of the Annual Report on Form 10-K for the fiscal year ended July 31, 2022.

<sup>2</sup> The figures in the table reflect transactions according to the settlement dates. For purposes of our unaudited consolidated financial statements included in this Form 10-Q, the impact of these repurchases is recorded according to the settlement dates.

<sup>3</sup> Includes 4,133 Common Stock shares surrendered by employees to pay taxes related to restricted stock awards.

<sup>4</sup> Our Board of Directors authorized the repurchase of 250,000 shares of Common Stock on June 14, 2012 and an additional 750,000 shares of Common Stock on March 11, 2019. These authorizations do not have a stated expiration date. The share numbers in this column indicate the number of shares of Common Stock that may yet be repurchased under these authorizations. Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by management.

**ITEM 4. MINE SAFETY DISCLOSURES**

Our mining operations are subject to regulation by the Mine Safety and Health Administration under authority of the Federal Mine Safety and Health Act of 1977, as amended. Information concerning mine safety violations or other regulatory matters required by section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 to this Quarterly Report on Form 10-Q.

------

**ITEM 6. EXHIBITS**

---

| | | |
|:---|:---|:---|
| Exhibit<br>No. | Description | SEC Document Reference |
| 31 | <u>[Certifications pursuant to Rule 13a–14(a).](odcex3101312023.htm)</u> | Filed herewith. |
| 32 | <u>[Certifications pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002.](odcex3201312023.htm)</u> | Furnished herewith. |
| 95 | <u>[Mine Safety Disclosures](odcex9501312023.htm)</u>. | Filed herewith. |
| 101.SCH | XBRL Taxonomy Extension Schema Document | Filed herewith. |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | Filed herewith. |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | Filed herewith. |
| 101.LAB | XBRL Taxonomy Extension Labels Linkbase Document | Filed herewith. |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase | Filed herewith. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101 | Filed herewith. |

---

Note: Stockholders may receive copies of the above listed exhibits, without fee, by written request to Investor Relations, Oil-Dri Corporation of America, 410 North Michigan Avenue, Suite 400, Chicago, Illinois 60611-4213, by telephone at (312) 321-1515 or by e-mail to info@oildri.com.

------

<u>SIGNATURES</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

OIL-DRI CORPORATION OF AMERICA

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Registrant)

BY <u>/s/ Daniel S. Jaffee&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Daniel S. Jaffee

Chairman, President and Chief Executive Officer

BY <u>/s/ Susan M. Kreh&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Susan M. Kreh

Chief Financial Officer

Dated: March 9, 2023

## Ex-31

**Exhibit 31:** 

**CERTIFICATIONS PURSUANT TO RULE 13A -14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED** 

**Certification of Principal Executive Officer** 

**(Section 302 of the Sarbanes-Oxley Act of 2002)** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.I, Daniel S. Jaffee, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.I have reviewed this quarterly report on Form 10-Q of Oil-Dri Corporation of America (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | March 9, 2023 |
| By: | /s/ Daniel S. Jaffee |
|  | Daniel S. Jaffee <br>Chairman, President and Chief Executive Officer |

---

------

**Exhibit 31 (continued):**

**Certification of a Principal Financial Officer** 

**(Section 302 of the Sarbanes-Oxley Act of 2002)** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.I, Susan M. Kreh, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Oil-Dri Corporation of America (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | March 9, 2023 |
| By: | /s/ Susan M. Kreh |
|  | Susan M. Kreh<br>Chief Financial Officer |

---

## Ex-32

**Exhibit 32:** 

**CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO** 

**THE SARBANES-OXLEY ACT OF 2002 CERTIFICATION** 

**Certification** 

Pursuant to 18 U.S.C. Section 1350, the undersigned officer of Oil-Dri Corporation of America (the "Company") hereby certifies that to the best of my knowledge the Company's Quarterly Report on Form 10-Q for the quarter ended January 31, 2023 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| | |
|:---|:---|
| Dated: | March 9, 2023 |
| /s/ Daniel S. Jaffee | /s/ Daniel S. Jaffee |
| Name: Daniel S. Jaffee <br>Title: Chairman, President and Chief Executive Officer | Name: Daniel S. Jaffee <br>Title: Chairman, President and Chief Executive Officer |

---

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.

**Certification**

Pursuant to 18 U.S.C. Section 1350, the undersigned officer of Oil-Dri Corporation of America (the "Company") hereby certifies that to the best of my knowledge the Company's Quarterly Report on Form 10-Q for the quarter ended January 31, 2023 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| | |
|:---|:---|
| Dated: | March 9, 2023 |
| /s/ Susan M. Kreh | /s/ Susan M. Kreh |
| Name: Susan M. Kreh<br>Title: Chief Financial Officer | Name: Susan M. Kreh<br>Title: Chief Financial Officer |

---

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.

## Ex-95

**Exhibit 95**

**MINE SAFETY DISCLOSURES**

Under section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K, each operator of a coal or other mine is required to include certain mine safety information in its periodic reports filed with the Securities and Exchange Commission. The table below includes this mine safety information for each mine facility owned and operated by Oil-Dri Corporation of America, or its subsidiaries, for the quarter ended January 31, 2023. Due to timing and other factors, our data may not agree with the mine data retrieval system maintained by the Mine Safety and Health Administration ("MSHA"). The columns in the table represent the total number of, and the proposed dollar assessment for, violations, citations and orders issued by MSHA during the period upon periodic inspection of our mine facilities in accordance with the referenced sections of the Federal Mine Safety and Health Act of 1977, as amended (the "Mine Act"), described as follows:

Section 104 Significant and Substantial Violations: Total number of violations of mandatory health or safety standards that could significantly and substantially contribute to the cause and effect of a coal or other mine safety or health hazard.

Section 104(b) Orders: Total number of orders issued due to a failure to totally abate, within the time period prescribed by MSHA, a violation previously cited under section 104, which results in the issuance of an order requiring the mine operator to immediately withdraw all persons from the mine.

Section 104(d) Citations and Orders: Total number of citations and orders issued for unwarrantable failure of the mine operator to comply with mandatory health and safety standards. The violation could significantly and substantially contribute to the cause and effect of a safety and health hazard, but the conditions do not cause imminent danger.

Section 110(b)(2) Flagrant Violations: Total number of flagrant violations defined as a reckless or repeated failure to make reasonable efforts to eliminate a known violation of a mandatory health or safety standard that substantially and proximately caused, or reasonably could have been expected to cause, death or serious bodily injury.

Section 107(a) Imminent Danger Orders: Total number of orders issued when an imminent danger is identified which requires all persons to be withdrawn from area(s) in the mine until the imminent danger and the conditions that caused it cease to exist.

Total Dollar Value of Proposed MSHA Assessments: Each issuance of a citation or order by MSHA results in the assessment of a monetary penalty. The total dollar value presented includes any contested penalties.

Legal Actions Pending, Initiated or Resolved: Total number of cases pending legal action before the Federal Mine Safety and Health Review Commission as of the last day of the reporting period or the number of such cases initiated or resolved during the reporting period.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | | | | | Legal Actions | Legal Actions | Legal Actions |
| Mine location | Section 104 "Significant and Substantial" Violations | Section 104(b)<br>Orders | Section 104(d)<br>Citations and Orders | Section 110(b)(2) Flagrant Violations | Section 107(a) Imminent Danger Orders | Total Dollar Value of Proposed MSHA Assessments | Pending as of Last Day of Period | Initiated During Period | Resolved During Period |
|  | (#) | (#) | (#) | (#) | (#) | ($) | (#) | (#) | (#) |
| Ochlocknee, Georgia |  |  |  |  |  |  |  |  |  |
| Ripley, Mississippi |  |  |  |  |  | 13960 |  |  |  |
| Mounds, Illinois | 6 | 1 |  |  |  | 28277 |  |  |  |
| Blue Mountain, Mississippi |  |  |  |  |  | 1070 |  |  |  |
| Taft, California |  |  |  |  |  |  |  |  |  |

---

We had no mining-related fatalities at any of our facilities during the three months ended January 31, 2023. During this period we also received no written notices from MSHA under section 104(e) of the Mine Act of (i) a pattern of violations of mandatory health or safety standards that are of such nature as could have significantly and substantially contributed to the cause and effect of coal or other mine health or safety hazards; or (ii) the potential to have such a pattern. All legal actions pending and initiated during the period were contests of proposed penalties.